[1]
|
Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004[J]. CA Cancer J Clin, 2004, 54(1):8-29. |
[2]
|
Yanagawa T, Watanabe H, Inoue T, et al. Carbonll-eholine positron emission tomography in musculoskeletal tumors:comparison with fluorine-18 fluorodeoxyglucose positron emission tomography[J]. J Comput Assist Tomogr, 2003, 27(2):175-182. |
[3]
|
Zhang H, Tian M, Riuchi N, et al. 11C-choline PET for the detection of bone and soft tissue tummours in comparison with FDG PET[J]. Nucl Med Commun, 2003, 24(3):273-279. |
[4]
|
郭喆,张锦明.11C-胆碱在PET肿瘤显像中的应用[J].同位素,2005,18(3):178-182.
|
[5]
|
De Jong IJ, Pruim J, Elsinga PH, et al. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET[J]. J Nucl Med, 2003, 44(3):331-335. |
[6]
|
Hara T, Kosaka N. Kishi H. PET imaging of prostate cancer using carbon-11-choline[J]. J Nucl Med, 1998, 39(6):990-995. |
[7]
|
Kotzerke J, Prang J, Neumaier B. et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma[J]. Eur J Nucl Med, 2000, 27(9):1415-1419. |
[8]
|
Picchio M. Messa C, Landoni C, et al. Value of[11C] cholinepositron emission tomography for re-staging prostate:a comparison with[18F] fluorodexyglucose-positron emission tomography[J]. J Urol, 2003, 169(4):1337-1340. |
[9]
|
Price D, Coleman R, Liao R, et al. Comparison of[18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer[J]. J Urol, 2002, 168(1):273-280. |
[10]
|
Kotzerke J, Volkmer BG, Glatting G, et al. Intraindividual comparison of[11C] acetate and[11C] choline PET for detection of metastases of prostate cancer[J]. Nuklearmedizin, 2003, 42(1):25-30. |
[11]
|
Kotzerke J, Volkmer BG, Neumaier B, et al. Carbon-llacetate positron emission tomography can detect local recurrence of prostate cancer[J].Eur J Nucl Med Mol Imaging, 2002, 29(10):1380-1384. |
[12]
|
Tóth G, Lengyel Z, Balkay L, et al. Detection of prostate cancer with 11C-methionine positron emission tomography[J]. J Urol, 2005, 173(1):66-69. |
[13]
|
Nañez R, Macapinlac HA, Yeung HW, et al. Combained 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer[J]. J Nucl Med, 2002, 43(1):46-55. |